Milano

Showing 1-5 of 5 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Bioengineered Islet Organs to Accelerate Clinical Translation in T1D (BIO-ACT)	Università Vita-Salute San Raffaele	Lorenzo Piemonti	Cures	01-February-2026 to 31-January-2029	$1,519,453.20
Critical Quality Attributes (CQAs)-Guided Selection of GMP-Compliant iPSC Lines for β Cell Replacement Therapy	Università Vita-Salute San Raffaele	Lorenzo Piemonti	Cures	01-February-2026 to 31-January-2028	$358,418.00
Impact of NK cells on the outcome of transplantation in patients with Type 1 Diabetes	Università Vita-Salute San Raffaele	Lorenzo Piemonti	Cures	01-January-2023 to 31-December-2026	$699,918.00
Ladarixin and Antithymocyte Globulin (ATG) in New Onset Type1 Diabetes	Università Vita-Salute San Raffaele	Lorenzo Piemonti	Cures	01-February-2025 to 31-January-2028	$99,669.10
Late pre-clinical validation of safety and long-term functionality of hypoimmunogenic iPSC-derived β cells into fully humanized transgenic mouse model of Type 1 Diabetes.	Università Vita-Salute San Raffaele	Lorenzo Piemonti	Cures	01-December-2024 to 30-November-2027	$999,995.70